Restless legs syndrome case study one: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
===Controversies=== | ===Controversies=== | ||
Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation <ref>* [http://www.rls.org/NETCOMMUNITY/Page.aspx?&pid=471&srcid=-2 RLS Foundation]</ref> received 44% of its $1.4 million in funding from these pharmaceutical groups<ref>[http://www.newscientist.com/channel/health/mg19225755.100-patient-groups-special-swallowing-the-best-advice.html Marshall, Jessica, and Peter Aldhous. "Patient Groups Special." New Scientist, 10/26/06]</ref>. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients. | Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation <ref>* [http://www.rls.org/NETCOMMUNITY/Page.aspx?&pid=471&srcid=-2 RLS Foundation]</ref> received 44% of its $1.4 million in funding from these pharmaceutical groups<ref>[http://www.newscientist.com/channel/health/mg19225755.100-patient-groups-special-swallowing-the-best-advice.html Marshall, Jessica, and Peter Aldhous. "Patient Groups Special." New Scientist, 10/26/06]</ref>. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients. | ||
==References== | ==References== | ||
Revision as of 15:58, 10 June 2013
|
Restless legs syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Restless legs syndrome case study one On the Web |
|
American Roentgen Ray Society Images of Restless legs syndrome case study one |
|
Risk calculators and risk factors for Restless legs syndrome case study one |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future or Investigational Therapies
Controversies
Recently, several major pharmaceutical companies are reported to be marketing drugs without an explicit approval for RLS, which are "off-label" applications for drugs approved for other diseases. The Restless Leg Foundation [1] received 44% of its $1.4 million in funding from these pharmaceutical groups[2]. This has called into question the neutrality of this group (significant conflict of interest issue) and the course of action which they recommend to RLS patients.